2025年全球数位治疗市场报告

近年来，数位治疗市场呈指数级增长，从2024年的87.3亿美元成长到2025年的109.3亿美元，复合年增长率达25.2%。预测期内的成长主要受人口老化和慢性病需求、数位医疗的普及、医疗成本和效率、远端患者监护以及疫情等因素所驱动。

预计未来几年，数位治疗市场规模将呈指数级增长，到2029年将达到295.6亿美元，复合年增长率为28.2%。预测期内的成长可归因于个人化医疗、医疗资料互通性、基于价值的照护模式的日益普及，对心理健康和福祉、医疗保健可近性和公平性的日益关注，网路安全和资料保护的不断扩展，以及对人口健康管理需求的不断增长。预测期内的主要趋势包括物联网设备和感测器的扩展、医疗保健领域的人工智慧、穿戴式健康技术、技术进步和产品创新。

数位疗法 (DTx) 是指透过复杂的软体应用程式向患者提供实证治疗方法的产品。这些应用程式旨在预防、管理和治疗各种医疗状况和疾病。

数位治疗产品的主要类别是设备和软体。数位治疗设备提供介入措施，用于预防、管理或治疗疾病或医学病症。数位治疗设备包含监测药物使用情况和位置的感测器。数位治疗的销售管道包括企业对企业 (B2B) 和企业对消费者 (B2C)。数位治疗可应用于预防、治疗和护理。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 全新报告系列的一部分，该系列提供数位治疗市场统计数据，例如全球数位治疗行业市场规模、各地区市场份额、各竞争对手的市场份额、详细的数位治疗细分市场、市场趋势和商业机会，以及在数位治疗行业取得成功所需的数据。本数位治疗市场研究报告全面展望了所有必要信息，并深入分析了该行业的现状和未来发展趋势。

预测的五年成长率为28.2%，较我们先前对该市场的预测略有下降0.3%。下降的主要原因是美国与其他国家之间的关税影响，这可能会直接影响到美国，导致来自英国和爱尔兰等主要地区的认知行为疗法软体平台和食品药物管理局(FDA) 批准的医疗设备零件的供应链中断。

智慧型手机和平板电脑的快速普及，以及医疗保健应用程式的预期广泛应用，预计将推动数位治疗市场的持续成长。智慧型手机和平板电脑上医疗保健应用程式的广泛应用带来了许多益处，包括减少用药错误、增强预防性护理以及提高人员分配的准确性。根据英国非营利组织GSMA（全球行动通讯系统协会）发布的《2023年行动网路连线状况报告》，2022年，全球超过一半的人口（54%）将拥有智慧型手机。智慧型手机的广泛普及是数位治疗市场的关键驱动力，创造了有利于创新治疗性介入发展的环境。

慢性病盛行率的上升是推动数位治疗市场扩张的关键因素。慢性病的特征是需要长期治疗，且严重影响个人的日常生活。作为软体为基础的介入手段，数位治疗提供实证治疗方案，增强慢性病管理，为患者提供新的治疗选择。根据美国疾病管制与预防中心2022年7月发布的数据，美国每10个成年人中就有6人患有慢性病，每10人中就有4人患有两种或两种以上的慢性病，​​例如心臟病、糖尿病和慢性肺病。慢性病的盛行率显着推动了数位治疗市场的成长轨迹。

技术创新是数位治疗市场的新兴趋势，产业领导者专注于开发先进的解决方案以增强其市场占有率。德国领先的製药公司勃林格殷格翰和美国医疗保健数位治疗公司 Click Pharmaceuticals 合作开发和商业化一种针对思觉失调症患者的数位药物。该合作伙伴关係价值超过 5 亿美元，凸显了两家公司对利用技术进步的承诺。提案的治疗药物 CT-155 将是基于 Click 技术平台开发的行动应用程序，展示创新数位解决方案在治疗领域的整合。这项策略性伙伴关係关係反映了业界致力于推进和整合技术，以改善数位治疗市场的治疗选择和患者预后。

数位治疗市场的主要企业正在积极开发创新的订购、履约平台，以服务慢性病患者。例如，DTx Connect 平台旨在透过软体直接向患者提供治疗性介入，以应对各种疾病和障碍，包括心理健康问题和糖尿病。 2022 年 7 月，美国製药解决方案公司 AmerisourceBergen 宣布推出 DTx Connect，这是一个完全整合的订购、配药和履约平台。 DTx Connect 平台的主要功能包括与电子健康记录(EMR) 无缝集成，使医生能够透过电子处方工作流程存取和开立处方笺和非处方笺数位疗法。该平台还有助于监测患者的依从性，从而简化医疗保健提供者的流程。

2023 年 7 月，Big Health 收购了 Limbix，收购金额不详，旨在扩大其现有产品系列。 Big Health 的产品组合包括失眠治疗药物 Threepio 和焦虑治疗药物日间行车灯。收购 Limbix 将增加 Sparklex 和另一种正在开发的用于治疗焦虑的青少年药物。 Limix 是一家总部位于美国的数位治疗供应商，将为 Big Health 的产品组合增添宝贵资产，增强其提供全面数位治疗解决方案的能力。此次收购反映了数位治疗市场的动态格局，标誌着 Big Health 扩大产品系列、满足不同健康状况患者的多样化需求的策略性倡议。

数位治疗市场的主要参与者包括 Omada Health Inc.、WellDoc Inc.、2Morrow Inc.、Propeller Health、Pear Therapeutics、Canary Health Inc.、Noom Health Inc.、Akili Interactive Labs、Better Therapeutics、Happify Health、Kaia Health、Medtronic plc、TelHealthc、Better Therapeutics、Happify Health. Health、SilverCloud Health、Biofourmis Inc.、Prosoma、Virta Health Corp.、One Drop Inc.、Lark Health、Riva、Xealth 和 CogniFit Ltd.。

2024年，北美是数位治疗市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。数位治疗市场分析报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

数位治疗市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

数位治疗市场涵盖用于治疗疾病、管理病情或改善健康功能的产品销售。此市场的价值是指“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球数位治疗：PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球数位治疗市场：成长率分析
• 全球数位治疗市场表现：规模与成长，2019-2024
• 全球数位治疗市场预测：2024-2029 年及 2034 年规模与成长
• 全球数位治疗：总目标市场（TAM）

第六章 市场细分

• 全球数位治疗市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 软体
• 装置
• 全球数位治疗市场：按销售管道、业绩和预测，2019-2024 年、2024-2029 年、2034 年
• 企业对企业（B2B）
• 企业对消费者（B2C）
• 全球数位治疗市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 预防性应用
• 治疗或护理相关应用
• 全球数位治疗市场：依软体（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
• 行动应用程式
• 网路为基础的平台
• 数位治疗软体
• 全球数位治疗市场：按设备（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 穿戴式装置
• 生物感测器
• 数位治疗设备

第七章 区域和国家分析

• 全球数位治疗市场：区域表现与预测（2019-2024 年、2024-2029 年及 2034 年）
• 全球数位治疗市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 数位治疗市场：竞争格局
• 数位治疗市场：公司简介
  • Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Propeller Health Overview, Products and Services, Strategy and Financial Analysis
  • Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Canary Health Inc.
• Noom Health Inc.
• Akili Interactive Labs
• Better Therapeutics
• Happify Health
• Kaia Health
• Medtronic plc
• Teladoc Health Inc.
• Fitbit Health Solutions
• EMulate Therapeutics
• BigHealth
• DarioHealth
• IQVIA
• JOGO Health
• SilverCloud Health

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年数位治疗市场：提供新机会的国家
• 2029年数位治疗市场：细分领域带来新机会
• 2029年数位治疗市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.

The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics market size has grown exponentially in recent years. It will grow from $8.73 billion in 2024 to $10.93 billion in 2025 at a compound annual growth rate (CAGR) of 25.2%. The growth in the historic period can be attributed to aging population and chronic diseases, digital health adoption, healthcare costs and efficiency, remote patient monitoring, and pandemic-induced demand.

The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $29.56 billion in 2029 at a compound annual growth rate (CAGR) of 28.2%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine, health data interoperability, value-based care models, increasing mental health and well-being focus, healthcare access and equity, growing cybersecurity and data protection, growing demand for population health management. Major trends in the forecast period include expansion of iot devices and sensors, artificial intelligence in healthcare, wearable health technology, technological advancements, and product innovations.

The forecast of 28.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for cognitive behavioral therapy software platforms and Food and Drug Administration (FDA)-cleared medical device components, sourced from key regions such as the UK and Ireland, which could lead to delayed prescription digital treatment availability and increased development costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in the use of smartphones and tablets, complemented by the widespread adoption of healthcare apps, is expected to drive the growth of the digital therapeutics market in the foreseeable future. The prevalence of smartphones and tablet-based healthcare apps brings about numerous advantages, including a reduction in medication errors, facilitating preventive care, and improving staffing accuracy. According to the State of Mobile Internet Connectivity Report 2023 by Groupe Speciale Mobile Association (GSMA), a UK-based non-profit organization, the year 2022 saw more than half of the world's population (54%) owning smartphones. This widespread use of smartphones is a significant driver for the digital therapeutics market, fostering a conducive environment for the growth of innovative therapeutic interventions.

The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.

An emerging trend in the digital therapeutics market is technological innovation, with major industry players focusing on developing advanced solutions to strengthen their market presence. Boehringer Ingelheim, a leading pharmaceutical company based in Germany, and Click Pharmaceuticals, a US-based prescription digital therapeutics business, have entered into a collaboration to develop and commercialize a digital medication for schizophrenia patients. This collaboration, valued at over $500 million, underscores the commitment to leveraging technological advancements. The proposed treatment, CT-155, will be a mobile app developed on Click's technology platform, showcasing the integration of innovative digital solutions in the field of therapeutics. This strategic partnership reflects the industry's dedication to advancing and integrating technology to enhance treatment options and patient outcomes in the digital therapeutics market.

Major players in the digital therapeutics market are actively developing innovative ordering, dispensing, and fulfillment platforms to cater to patients dealing with chronic diseases. An exemplar in this regard is DTx Connect, a platform designed to deliver therapeutic interventions directly to patients through software, addressing a spectrum of diseases and disorders including mental health issues and diabetes. In July 2022, AmerisourceBergen, a pharmaceutical solutions organization based in the US, introduced DTx Connect, a fully integrated platform for ordering, dispensing, and fulfillment. Key features of the DTx Connect platform include seamless integration with electronic medical records (EMR), enabling physicians to access and prescribe both prescription and non-prescription digital therapeutics through their e-prescribing workflow. The platform also facilitates the monitoring of patient fulfillment, streamlining the process for healthcare providers.

In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.

Major companies operating in the digital therapeutics market include Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Riva, Xealth, CogniFit Ltd.

North America was the largest region in the digital therapeutics market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutic market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Software; Devices
• 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
• 3) By Application: Preventive Applications; Treatment Or Care-Related Applications
• Subsegments:
• 1) By Software: Mobile Applications; Web-Based Platforms; Digital Therapeutics Software
• 2) By Devices: Wearable Devices; Biosensors; Digital Therapeutic Devices
• Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Propeller Health; Pear Therapeutics; Canary Health Inc.; Noom Health Inc.; Akili Interactive Labs; Better Therapeutics; Happify Health; Kaia Health; Medtronic plc; Teladoc Health Inc.; Fitbit Health Solutions; EMulate Therapeutics; BigHealth; DarioHealth; IQVIA; JOGO Health; SilverCloud Health; Biofourmis Inc.; Prosoma; Virta Health Corp.; One Drop Inc.; Lark Health; Riva; Xealth; CogniFit Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics Market Characteristics

3. Digital Therapeutics Market Trends And Strategies

4. Digital Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digital Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digital Therapeutics Market Growth Rate Analysis
• 5.4. Global Digital Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digital Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digital Therapeutics Total Addressable Market (TAM)

6. Digital Therapeutics Market Segmentation

• 6.1. Global Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Devices
• 6.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Business-To-Business (B2B)
• Business-To-Consumers (B2C)
• 6.3. Global Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preventive Applications
• Treatment Or Care-Related Applications
• 6.4. Global Digital Therapeutics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Web-Based Platforms
• Digital Therapeutics Software
• 6.5. Global Digital Therapeutics Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Devices
• Biosensors
• Digital Therapeutic Devices

7. Digital Therapeutics Market Regional And Country Analysis

• 7.1. Global Digital Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digital Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics Market

• 8.1. Asia-Pacific Digital Therapeutics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics Market

• 9.1. China Digital Therapeutics Market Overview
• 9.2. China Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics Market

• 10.1. India Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics Market

• 11.1. Japan Digital Therapeutics Market Overview
• 11.2. Japan Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics Market

• 12.1. Australia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics Market

• 13.1. Indonesia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics Market

• 14.1. South Korea Digital Therapeutics Market Overview
• 14.2. South Korea Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics Market

• 15.1. Western Europe Digital Therapeutics Market Overview
• 15.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics Market

• 16.1. UK Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics Market

• 17.1. Germany Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics Market

• 18.1. France Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics Market

• 19.1. Italy Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics Market

• 20.1. Spain Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics Market

• 21.1. Eastern Europe Digital Therapeutics Market Overview
• 21.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics Market

• 22.1. Russia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics Market

• 23.1. North America Digital Therapeutics Market Overview
• 23.2. North America Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics Market

• 24.1. USA Digital Therapeutics Market Overview
• 24.2. USA Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics Market

• 25.1. Canada Digital Therapeutics Market Overview
• 25.2. Canada Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics Market

• 26.1. South America Digital Therapeutics Market Overview
• 26.2. South America Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics Market

• 27.1. Brazil Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics Market

• 28.1. Middle East Digital Therapeutics Market Overview
• 28.2. Middle East Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics Market

• 29.1. Africa Digital Therapeutics Market Overview
• 29.2. Africa Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Digital Therapeutics Market Competitive Landscape
• 30.2. Digital Therapeutics Market Company Profiles
  • 30.2.1. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. WellDoc Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. 2Morrow Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Propeller Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pear Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics Market Other Major And Innovative Companies

• 31.1. Canary Health Inc.
• 31.2. Noom Health Inc.
• 31.3. Akili Interactive Labs
• 31.4. Better Therapeutics
• 31.5. Happify Health
• 31.6. Kaia Health
• 31.7. Medtronic plc
• 31.8. Teladoc Health Inc.
• 31.9. Fitbit Health Solutions
• 31.10. EMulate Therapeutics
• 31.11. BigHealth
• 31.12. DarioHealth
• 31.13. IQVIA
• 31.14. JOGO Health
• 31.15. SilverCloud Health

32. Global Digital Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Market

34. Recent Developments In The Digital Therapeutics Market

35. Digital Therapeutics Market High Potential Countries, Segments and Strategies

• 35.1 Digital Therapeutics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digital Therapeutics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digital Therapeutics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer